Whole-exome sequencing in 8 patients, including O. viverrini–associated CCA, has revealed frequent mutations in TP53 (44.4%), KRAS (16.7%), and SMAD4 (16.7%) [131]. Here, KRAS is linked to cholangiocarcinoma.